IMS Health has bought DecisionView to add patient recruitment planning software to its healthcare unit.
Buying San Francisco-based DecisionView gives IMS Health the web-based software StudyOptimizer for forecasting and tracking patient enrolment into clinical trials. IMS Health will make the system part of its healthcare business which offers outcomes research, trial optimisation, and other services.
“Our clients recognize the need for more data and analytics to guide their clinical trial enrolment and performance management activities – and they’re actively looking for innovative solutions. The combination of DecisionView and IMS is powerful”, Linda Drumright, DecisionView CEO, said.